<figure class="table" style="width:100%;"><table class="ck-table-resized"><colgroup><col style="width:71.63%;"><col style="width:28.37%;"></colgroup><tbody><tr><td><figure class="image"><img style="aspect-ratio:761/427;" src="/api/download/dllFZ1lRNTQwcXZhOWJmVnVYV1lKRy9kb0twVnJMeVAwdXB3Uk1NNXFQNTlmRmtMUWVGVkMyUzhVTlJwTmJ5Vy9uZG5WKytZZEJrMFgvUWplaDNqU2c9PQ" width="761" height="427"></figure></td><td><figure class="image"><img style="aspect-ratio:421/808;" src="/api/download/dllFZ1lRNTQwcXZhOWJmVnVYV1lKTWFwTGFtQXBmbzUwblhRMnA0bmtLQzNTeGFCTUppMXFBaFowTklDR2xBblVQRGxFUUxtR2k1QWgxNTJ1VXBRaVE9PQ" width="421" height="808"></figure></td></tr></tbody></table></figure><p>“Critical”과 “PrcEff” 바이오마커가 함께 상승하였습니다. 이것은 심장눌림증 위험도가 높음을 시사합니다.<br>&nbsp;</p><p>ECG Source:</p><p>https://wikem.org/wiki/Pericardial_effusion_and_tamponade</p>